drugset

drugset / Trial / NCT07645807

Study to Evaluate the Adjunctive Effect of CreNeuroS™ CNS Fish Oil Plus Softgels in Patients With Major Depressive Disorder Receiving Escitalopram.

NCT07645807 ↗

Not yet recruiting 80 enrolled Sichuan Credit Pharmaceutical Co., Ltd. Vivotech Research Lab Pvt Ltd · collab

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

To evaluate the efficacy of adjunctive CreNeuroSTM CNS Fish Oil Plus Softgels in patients with Major Depressive Disorder receiving escitalopram.

Timeline

Start: 2026-06-11
Primary completion: 2027-01
Completion: 2027-01

Publications

Background Sinha S, Chary S, Thakur P, Talluri L, Reddy M, Verma KK, Saha P, Gupta VB, Ramaiah KA, Khanum SZ. A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive Disorder. Cureus. 2021 Jul 28;13(7):e16689. doi: 10.7759/cureus.16689. eCollection 2021 Jul.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CreNeuroSTM CNS Fish Oil Plus Softgels	Unknown	—	—
Background	Escitalopram	Small molecule	—	—

Indications

No indication recorded.